Hepatitis B vaccine.
Capiau
C
C
SmithKline Beecham Biologicals, Rixensart, Belgium.
D000818:Animals; D001709:Biotechnology; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification; D017325:Hepatitis B Vaccines / Q000276:immunology / Q000302:isolation & purification* / Q000592:standards; D006801:Humans; D008970:Molecular Weight; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D012441:Saccharomyces cerevisiae / Q000235:genetics; D014614:Vaccines, Synthetic / Q000276:immunology / Q000302:isolation & purification / Q000592:standards
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic